Home > Drug Search >
  • company_query: Alnylam
  •   > 
Drug Filter
Category:
chemistry (33) biology (10)
Status:
Approved (5) Phase Ⅲ (6) Phase Ⅱ (17) Phase Ⅰ (15)
Clinical Stage:
Pending (7) Active (24) Discontinued (7)
Bio-Type:
Vaccine (2) Recombinant enzyme (1) Recombinant cytokines (1) Other recombinant protein (1) Whole antibody (2)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (5) Amyotrophic lateral sclerosis (ALS) (1) Anemia (1) Asthma (1) Benign prostatic hypertrophy (1) Chronic idiopathic constipation (CIC) (1) Delayed graft function (1) Deep vein thrombosis (DVT) (1) Endometriosis (1) Pancreatitis (1) HBV infection (1) HCV infection (2) Heart failure (1) Hypercalcemia (1) Hypercholesterolemia (1) Hyperparathyroidism (1) Hypertension (2) Irritable bowel syndrome (IBS) (1) Rabies (1) Myelodysplastic syndrome (MDS) (1) Nausea and vomiting (1) Obesity (1) Osteomalacia (1) Overactive bladder (OAB) (1) Parkinson's disease (PD) (1) Rheumatoid arthritis (RA) (1) Rickets (1) Smoking cessation (1) Solid tumours (2) Type 2 diabetes (3) Ulcerative colitis (1) Uterine fibroids (1) Maintenance dialysis (1) Pain (1) Transthyretin amyloidosis (1) Systemic inflammatory response syndrome (SIRS) (1) Renal carcinoma (1) Lower urinary tract symptoms (LUTS) (1) Brain injury (1) Gout (1) Thrombosis (1) Mesothelioma (1) Urinary tract stones (1) Liver cancer (1) Cardiovascular disorders (1) Shock (1)
Aprv. Year:
2001 (1) 2004 (1) 2006 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top